Abstract
Aim
Adverse perinatal outcomes have been linked to alterations in vitamin
D-binding protein (VDBP) levels. We assessed the predictive value of serum
and cervicovaginal fluid VDBP for preterm birth, as well as to measure VDBP
in threatened preterm labor (TPL) and preterm premature rupture of membranes
(PPROM).
Methods
A total of 138 pregnant women were divided into three groups in this
prospective case-control study: TPL(n=59), PPROM (n=43) and control (n=36).
Also, all patients were divided into two groups according to whether the
latency period was shorter (n=48) or longer than 48 hours (n=90). The VDBP
levels were measured using an enzyme-linked immunosorbent assay kit and
compared between groups.
Results
Cervicovaginal fluid and serum VDBP levels were lower in the TPL and PPROM
groups than controls. Cervicovaginal fluid VDBP<0.63ng/ml predicted
preterm birth with 81.58% sensitivity and 53.23% specificity (AUC=0.713,
p<0.001). Serum VDBP≤ 0.26ng/ml predicted preterm birth with 61.84%
sensitivity and 64.52% specificity (AUC=0.629, p=0.008). No significant
difference was detected between serum and cervicovaginal fluid VDBP levels
for predicting preterm birth (p=0.018). Moreover, cervicovaginal fluid
VDBP>0.44ng/ml predicted latency period≤48 hours with 43.75% sensitivity
and 94.44% specificity (AUC=0.694, p<0.001), while serum VDBP did not
predict a latency period shorter than 48 hours (AUC=0.515, p=0.771).
Conclusions
Both serum and cervicovaginal VDBP may be valuable markers for predicting
preterm birth. Although no difference was found between serum and
cervicovaginal VDBP in terms of predictive role, cervicovaginal fluid VDBP
may be one step ahead of serum VDBP with the ability to predict a short
latency period
Keywords
cervicovaginal vitamin D-binding protein - latency period - preterm birth - serum
vitamin D-binding protein